Dopamine D2 receptor agonists protect against ischaemia-induced hippocampal neurodegeneration in global cerebral ischaemia

European Journal of Pharmacology

Volumn 352, Issue 1, 1998, Pages 37-46

  O'Neill, Michael J ^a   Hicks, Caroline A ^a   Ward, Mark A ^a   Cardwell, Geraldine P ^a   Reymann, Jean Michel ^b   Allain, Hervé ^b   Bentué Ferrer, Daniele ^b  

^a ELI LILLY AND COMPANY   (United States)

^b Inst de Rech Contre le Cancer IRCC   (France)

Author keywords

Bromocriptine; Cerebral ischaemia; Dopamine D1 D2 receptor; Lisuride; Pergolide; SCH 23390; SKF 38393

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; BROMOCRIPTINE; DOPAMINE 2 RECEPTOR STIMULATING AGENT; HALOPERIDOL; LISURIDE; PERGOLIDE; PERGOLIDE MESILATE; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; NEUROPROTECTIVE AGENT;

ANIMAL EXPERIMENT; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; GERBIL; HIPPOCAMPUS; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; ANIMAL; DRUG POTENTIATION; PATHOLOGY;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; 2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; ANIMALS; BRAIN ISCHEMIA; BROMOCRIPTINE; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; GERBILLINAE; HALOPERIDOL; HIPPOCAMPUS; LISURIDE; NEUROPROTECTIVE AGENTS; PERGOLIDE; RECEPTORS, DOPAMINE D2;

EID: 0031594974     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00333-1     Document Type: Article

References (54)

1. Asanuma, M., Ogawa, N., Nishibayashi, S., Kawai, M., Kondo, Y., Iwata, E., 1995. Protective effects of pergolide on dopamine levels in 6-hydroxydopamine-lesioned mouse brain. Arch. Int. Pharmacodyn. Ther. 329, 221-230.
2. Baker, A.J., Zornow, M.H., Scheller, M.S., Yaksh, T.L., Skilling, S.R., Smullin, D.H., Larson, A.A., Kuczenski, R., 1991. Changes in extracellular concentrations of glutamate, aspartate, glycine, dopamine, serotonin and dopamine metabolites after transient global ischemia in the rabbit brain. J. Neurochem. 57, 1370-1379.
3. Bendele, A.M., Spaethe, S.M., Benslay, D.N., Bryant, H.U., 1991. Anti-inflammatory activity of pergolide, a dopamine receptor agonist. J. Pharmacol. Exp. Ther. 259, 169-175.
4. Bentué-Ferrer, D., Decombe, R., Saïag, B., Allain, H., Van den Driessche, J., 1993. L-type voltage-dependent calcium channels do not modulate aminergic neurotransmitter release induced by transient global cerebral ischaemia: an in vivo microdialysis study. Exp. Brain Res. 93, 288-292.
5. Bentué-Ferrer, D., Bellissant, E., Decombe, R., Allain, H., 1994. Temporal profile of aminergic neurotransmitter release in striatal dialysates in rats with post-ischemic seizures. Exp. Brain Res. 97, 437-443.
6. Benveniste, H., Drejer, J., Schousboe, A., Dimer, N.H., 1984. Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J. Neurochem. 43, 1369-1374.
7. Brannan, T., Weinberger, J., Knott, P., Taff, I., Kaufmann, H., Togasaki, D., Nieves-Rosa, J., Maker, H., 1987. Direct evidence of acute, massive striatal dopamine release in gerbils with unilateral strokes. Stroke 18, 108-110.
8. Buisson, A., Plotkine, M., Boulu, R., 1991. Lesioning the substantia nigra reduces striatal infarct volume following focal ischemia in rats. Fundam. Clin. Pharmacol. 5, 645-647.
9. Buisson, A., Margaill, I., Callebert, J., Plotkine, M., Boulu, R.G., 1993. Mechanisms involved in the neuroprotective activity of a nitric oxide synthase inhibitor during focal cerebral ischemia. J. Neurochem. 61, 690-696.
10. Bullock, R., Graham, D.I., Swanson, S., McCulloch, J., 1994. Neuroprotective effect of AMPA receptor antagonist LY 293558 in focal cerebral ischemia in the cat. J. Cereb. Blood Flow Metab. 14, 466-471.
11. Caldwell, M.A., Reymann, J.M., Bentué-Ferrer, D., Allain, H., Leonard, B.E., 1996. The dopamine agonists lisuride and piribedil protect against behavioural and histological changes following four-vessel occlusion in the rat. Neuropsychobiology 34, 117-124.
12. Caldwell, M.A., Reymann, J.-M., Allain, H., Leonard, B.E., Bentue-Ferrer, D., 1997. Lisuride prevents learning and memory impairment and attenuates the increase in extracellular dopamine induced by transient global cerebral ischemia in rats. Brain Res. 771, 305-318.
13. Chan, P.H., Epstein, C.J., Sharp, F.R., Kinouchi, H., Kamii, H., Gafni, J., Chen, S.F., Carlson, E., 1994. SOD-1 transgenic mice: a model for the study of cerebral ischemia. In: Krieglstein, J., Oberpichler-Schwenk, H. (Eds.), Pharmacology of Cerebral Ischemia. Med-Pharm Scientific Publications, Stuttgart, pp. 277-286.
14. Choi, D.W., 1992. Excitotoxic cell death. J. Neurobiol. 23, 1261-1276.
15. Clark, W.M., Hazel, J.S., Coull, B.M., 1995. Lazaroids: CNS pharmacology and current research. Drugs 50, 971-983.
16. Clemens, J.A., Phebus, L.A., 1988. Dopamine depletion protects striatal neurons from ischaemia-induced cell death. Life Sci. 42, 707-713.
17. Clemens, J.A., Saunders, R.D., Ho, P.P., Phebus, L.A., Panetta, J.A., 1993. The antioxidant LY 231617 reduces global ischemic neuronal injury in rats. Stroke 24, 716-723.
18. Clow, A., Freestone, C., Lewis, E., Dexter, D., Sandler, M., Glover, V., 1993. The effect of pergolide and MDL-72974 on rat brain CuZn superoxide dismutase. Neurosci. Lett. 164, 41-43.
19. Damsma, G., Boisvert, D.P., Mudrick, L.A., Wenkstern, D., Fibiger, H.C., 1990. Effects of transient forebrain ischemia and parglycine on extracellular concentrations of dopamine, serotonin, and their metabolites in the rat striatum as determined by in vivo microdialysis. J. Neurochem. 54, 801-808.
20. Gill, R., Foster, A.C., Woodruff, G.N., 1987. Systemic administration of MK-801 protects against ischemia-induced hippocampal neurodegeneration in the gerbil. J. Neurosci. 7, 3343-3349.
21. Globus, M.Y.-T., Ginsberg, M.D., Dietrich, W.D., Busto, R., Scheinberg, P., 1987. Substantia nigra lesion protects against ischemic damage in the striatum. Neurosci. Lett. 80, 251-256.
22. Globus, M.Y.-T., Busto, R., Dietrich, W.D., Martinez, E., Valdes, I., Ginsberg, M.D., 1988. Effect of ischemia on in vivo release of striatal dopamine, glutamate and γ-aminobutyric acid studies by intracerebral microdialysis. J. Neurochem. 51, 1455-1464.
23. Glover, V., Clow, A., Sandler, M., 1993. Effects of dopaminergic drugs on superoxide dismutase: implications for senescence. J. Neural Transm. S 40, 37-45.
24. Green, E.J., Dietrich, W.D., Van Dijk, F., Busto, R., Markgraf, C.G., McCabe, P.M., Ginsberg, M.D., Schneiderman, N., 1992. Protective effects of brain hypothermia on behavior and histopathology following global cerebral ischemia in rats. Brain Res. 580, 197-204.
25. Hall, E.D., 1995. Inhibition of lipid peroxidation in central nervous trauma and ischemia. J. Neurol. Sci. 134, 79-83.
26. 3 agonist pramipexole against postischemic or methamphetamine-induced degeneration of nigrostriatal neurons. Brain Res. 742, 80-88.
27. Hashimoto, N., Matsumumoto, T., Mabe, H., Hashitani, T., Nishino, H., 1994. Dopamine has inhibitory and accelerating effects on ischemia-induced neuronal cell damage in the striatum. Brain Res. Bull. 33, 281-288.
28. Hirata, H., Ogawa, N., Haba, K., Asanuma, M., Chou, H., Mori, A., 1992. Effects of chronic administration of lisuride hydrogen maleate on aromatic amine and metabolite levels in the gerbil brain following bilateral common carotid ligation. Arch. Int. Pharmacodyn. Ther. 315, 5-15.
29. Javoy-Agid, J., 1992. Dopaminergic cell death in Parkinson's disease. In: Packer, L., Trilipko, L., Christen, Y. (Eds.), Free Radicals in the Brain: Aging, Neurological and Mental Disorders. Springer-Verlag, New York, pp. 99-108.
30. Jenner, P., Schapira, A.H.V., Marsden, C.D., 1992. New insights into the cause of Parkinson's disease. Neurology 42, 2241-2250.
31. Johnson, E.M., Greenlund, L.J.S., Akins, P.T., Hsu, C.Y., 1995. Neuronal apoptosis: current understanding of molecular mechanisms and potential role in ischemic brain injury. J. Neurotrauma 12, 843-852.
32. Liu, X.-H., Kato, H., Chen, T., Kato, K., Itoyama, Y., 1995. Bromocriptine protects against delayed neuronal death of hippocampal neurons following cerebral ischaemia in the gerbil. J. Neurol. Sci. 129, 9-14.
33. Marie, C., Mossiat, C., Beley, A., Bralet, J., 1992. α-Methyl-para-tyrosine pretreatment protects from striatal neuronal death induced by four-vessel occlusion in the rat. Neurochem. Res. 17, 961-965.
34. McCulloch, J., 1992. Excitatory amino acid antagonists and their potential for the treatment of ischaemic brain damage in man. Br. J. Clin. Pharmacol. 34, 106-114.
35. Mizuno, B.E., Mori, H., Kondo, T., 1994. Potential of neuroprotective therapy in Parkinson's disease. CNS Drugs 1, 45-56.
36. Nishibayashi, S., Asanuma, M., Kohno, M., Gomez-Vargas, M., Ogawa, N., 1996. Scavenging effects of dopamine agonists on nitric oxide radicals. J. Neurochem. 67, 2208-2211.
37. Nisoli, E., Tonello, C., Imhof, R., Scherschlicht, R., Da Prada, M., Carruba, M.O., 1993. Biochemical and behavioral evidence that Ro 41-9067 is a selective presynaptic dopamine receptor agonist. J. Pharmacol. Exp. Ther. 266, 97-105.
38. O'Neill, M., Hicks, C., Ward, M., 1996. Neuroprotective effects of 7-nitroindazole in the gerbil model of global cerebral ischaemia. Eur. J. Pharmacol. 310, 115-122.
39. O'Neill, M., Hicks, C., Ward, M., Panetta, J.A., 1997. Neuroprotective effects of the antioxidant LY 231617 and NO synthase inhibitors in global cerebral ischaemia. Brain Res. 760, 170-178.
40. Phebus, L.A., Clemens, J.A., 1989. Effects of transient, global, cerebral ischemia on striatal extracellular dopamine, serotonin and their metabolites. Life Sci. 44, 1335-1342.
41. 1A receptor agonists in rodent models of focal and global cerebral ischemia. Eur. J. Pharmacol. 203, 213-222.
42. Prehn, J.H.M., Welsch, M., Backhauß, C., Nuglish, J., Ausmerer, F., Karkoutly, C., Krieglstein, J., 1993. Effects of serotonergic drugs in experimental brain ischemia: evidence for a protective role of serotonin in cerebral ischemia. Brain Res. 630, 10-20.
43. Richards, D.A., Obrenovitch, T.P., Symon, L., Curzon, G., 1993a. Extracellular dopamine and serotonin in the rat striatum during transient ischaemia of different severities: a microdialysis study. J. Neurochem. 60, 18-136.
44. Richards, D.A., Obrenovitch, T.P., Johonson-Mora, A., Islekel, S., Symon, L., Curzon, G., 1993b. Effect of global ischaemia, under simulated penumbral conditions, on brain monoamine neurochemistry and subsequent neurological and histological deficits. J. Neurochem. 61, 1801-1807.
45. Sethy, V.H., Wu, H., Oostveen, J.A., Hall, E.D., 1997. Neuroprotective effects of the dopamine agonists pramipexole and bromocriptine in 3-acetylpyridine-treated rats. Brain Res. 754, 181-186.
46. Sheardown, M.J., Nielson, E.O., Hansen, A.J., Jacobsen, P., Honoré, T., 1990. 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo[f]quinoxaline: a neuro-protectant for cerebral ischemia. Science 247, 571.
47. Siesjö, B.K., 1992. Pathophysiology and treatment of focal cerebral ischemia: Part I. Pathophysiology. J. Neurosurg. 77, 169-184.
48. Tagaya, M., Matsumoto, M., Kitagawa, K., Niinobe, M., Ohtsuki, T., Hata, R., Ogawa, S., Handa, N., Mikoshiba, K., Kamada, T., 1992. Recombinant human superoxide dismutase can attenuate ischemic neuronal damage in gerbils. Life Sci. 51, 253-259.
49. Tissari, A.H., Lillgäls, M.S., 1993. Reduction of dopamine synthesis inhibition by dopamine autoreceptor activation in striatal synaptosomes with in vivo reserpine administration. J. Neurochem. 61, 231-238.
50. Wengenack, T.M., Curran, G.L., Poduslo, J.F., 1997. Postischemic, systemic administration of polyamine-modified superoxide dismutase reduces hippocampal CA1 neurodegeneration in rat global cerebral ischemia. Brain Res. 754, 46-54.
51. Xue, D., Huang, Z.-G., Smith, K.E., Buchan, A.M., 1992. Immediate or delayed mild hypothermia prevents focal cerebral infarction. Brain Res. 587, 66-72.
52. Yoshida, T., Limmroth, V., Irikura, K., Moskowitz, M.A., 1994. The NOS inhibitor, 7-nitroindazole, decreases focal infarct volume but not response to topical acetylcholine in pial vessels. J. Cereb. Blood Flow Metab. 14, 924-929.
53. Yoshikawa, T., 1993. Free radicals and their scavengers in Parkinson's disease. Eur. Neurol. 33, 60-68.
54. Yoshikawa, T., Minamiyama, Y., Naito, Y., Kondo, M., 1994. The antioxidant properties of dopamine agonist bromocriptine. J. Neurochem. 62, 1034-1038.